Clinical Trial Operations Strategy

Trial and staffing decisions your research program can defend.

Muriera Solutions builds the staffing, financial, and digital operations intelligence academic medical centers and cancer programs use to size their teams, price growth, and protect coordinators from burnout — scored, not guessed.

Portfolio Acuity Model TRIALNAV OASIS™
TRIALNAV OASIS Team Analytics dashboard — team burden, expert utilization, workload variance, risk score, and role competency heatmap

Live team analytics from TRIALNAV OASIS™ — burden, utilization, variance, and risk scored by role and experience level.

The Executive Challenge

Most programs are managing growth without operational intelligence.

Protocols keep getting more complex. Coordinators keep leaving. And FTE requests keep landing on a CFO's desk with no data behind them. Six pressures show up in nearly every program we assess.

Increasing protocol complexity

Every new trial changes the workload math — and few sites re-run it.

Coordinator burnout and turnover

Uneven caseloads push your best coordinators out first.

Unpredictable FTE demands

Hiring requests get built on instinct, not a defensible model.

Hidden financial deficits

Divisional margins stay invisible until they're already negative.

Sponsor performance pressure

Activation and enrollment targets tighten while staffing doesn't move.

Limited operational visibility

Leadership makes portfolio calls without a live view of the site.

Service Areas

Four ways we can optimize your operations

Each engagement draws from the same four disciplines — led by consultants with a minimum of 15 years in clinical trial site operations.

Workforce Transformation

  • —Staff-to-trial alignment
  • —FTE modeling & hiring justification
  • —Coordinator role optimization

Site Digital Transformation

  • —Implementation of TRIALNAV OASIS™
  • —Real-time dashboards & reporting
  • —Protocol complexity modeling

Process Improvement

  • —GAP & SWOT analysis
  • —Workflow standardization
  • —Portfolio & governance optimization

Special Area Builds

  • —Therapeutic area growth strategy
  • —Sponsor-specific trial readiness
  • —High-acuity specialty team modeling
The Engagement

A 4-week path from diagnosis to a defensible plan.

Three phases, run in sequence, each building the evidence base the next one needs.

01
Week 1

Diagnostic

  • Portfolio mapping
  • Staffing structure review
  • Financial baseline
  • Protocol complexity input
02
Weeks 2–3

Modeling

  • FTE variance analysis
  • Workload balancing scenarios
  • Margin and ROI forecasting
03
Week 4

Strategic Alignment

  • Staffing realignment plan
  • Governance recommendations
  • Growth strategy
  • Executive roadmap delivery
The Difference

Not another slide deck of recommendations.

Traditional advisory work stops at a report. Ours ships with the model behind it.

Aspect Traditional Consultants Muriera Solutions + OASIS™
Experience Often project-based or therapeutic advisory VP-level, scaled multi-site oncology and non-oncology research networks
Insight Retrospective analysis, generic benchmarking Real-time protocol complexity scoring, FTE modeling, dashboards
Tools Excel or static reports AI-powered TRIALNAV OASIS™, scenario simulation
Deliverables Recommendations only Full operational assessment, FTE model, 12–24 month roadmap
Expected Outcomes

What programs typically see.

Up to 40%

Typical improvement in staffing efficiency after a full engagement.

Defensible FTE hiring requests

Reduced coordinator burnout

Faster trial activation timelines

Transparent divisional financial performance

Sustainable research growth

Who's Behind The Model

25+ years running the programs she now advises.

Brenda Muriera

Brenda Muriera, RN, BSN, MS, CCRP

Founder Muriera Solutions, TRIALNAV, LLC · TRIALNAV OASIS™

Experience25+ years
CertificationsCCRP · GCP · FDA Compliance
EducationMS, International Research
AffiliationsSOCRA · SCRS · ONS · Women in Research Leadership
Based inPhoenix, AZ · Amsterdam, NL

Brenda Muriera is a senior clinical research operations consultant with 25+ years of progressive leadership experience transforming academic medical centers, health systems, and global research technology platforms — scaling oncology research programs and advising C-suite executives on workforce strategy and trial optimization.

She helped build and scale clinical research programs across a network spanning more than 10 states, supporting a portfolio of over 1,000 clinical trials and growing annual research revenue to more than $20 million. Her experience spans executive business development at IQVIA, clinical trial implementation consulting for integrated delivery systems, and more than a decade leading multicenter Phase I–III oncology trials at leading academic medical centers and health systems, including UT MD Anderson Cancer Center, CommonSpirit Health, Banner Health, UT Health Science Center, Cancer Treatment Centers of America, and Baylor College of Medicine.

In 2021, she founded TRIALNAV, LLC and developed TRIALNAV OASIS™—a real-time, AI-powered scoring platform that powers the assessment model featured on this page, helping research organizations evaluate readiness, identify operational gaps, and strengthen clinical trial performance.

Trusted Across Research Programs
Start The Conversation

Let's find out what your baseline program acuity score actually is.

A 30-day diagnostic starts with a 30-minute call. No deck, no pitch — just a look at where your program stands.

Book a Strategy Call Text 713-530-1405
Phone
713-530-1405
Locations
Phoenix, AZ · Amsterdam, NL